Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 2/3
×
INDUSTRY
×
Adenoviridae Infections
×
Clear all
Filters
3
NCT05305040
2024-05-16
Prevent
AlloVir
Phase 2/3
Terminated
451 enrolled
10 charts
NCT04693637
2024-05-09
Prevent
AlloVir
Phase 2/3
Completed
26 enrolled
16 charts
NCT01438112
2021-04-14
BOND
CG Oncology, Inc.
Phase 2/3
Terminated
22 enrolled